CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.
CVS Health (NYSE: CVS) reported fourth-quarter earnings that exceeded analyst expectations on Wednesday, driven by strong ...
Some analysts are more optimistic about CVS’ ability to navigate higher-than-expected medical costs in its insurance unit ...
CVS’s stock soared toward after its quarterly profit beat expectations by the widest margin in more than four years.
CVS Pharmacy thinks it has found a solution to customer complaints about locked display cases - but the cure may be worse ...
A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...
Retail pharmacy chain CVS Health (CVS) is scheduled to announce its results for the fourth quarter of 2024 before the market ...
Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...
Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday,2. Wall ...
CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...
10don MSN
CVS, which operates the nation's largest pharmacy chain, health insurer Aetna, and the pharmacy benefit manager Caremark, beat estimates on the top and bottom lines in the fourth quarter. Revenue rose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results